Power Law company profile

Avidity Biosciences

Biotech & Life Sciences · San Diego, United States · Founded 2013 · IPO 2020 Unicorn

Research, development, and manufacturing of drug candidates which include antibody-sirna complexes

Revenue

$19M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

18 investors on Avidity Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 18 investors entered at this stage

RTW Investments

Moore Venture Partners

Adage Capital

Farallon Capital Management

Eli Lilly

Alethea Capital Management

Janus Henderson Investors

EcoR1 Capital

Casdin Capital

Perceptive Advisors

F-Prime

Logos Capital

Wellington Management

Brace Pharma

Boxer Capital

Takeda

Cormorant Asset Management

RA Capital Management

Avidity Biosciences mafia

Startups founded by Avidity Biosciences alumni

Former Avidity Biosciences employees who went on to start their own companies. Sorted by Dealroom signal score.

MBX BiosciencesEst. 2018

P. Kent HawrylukUnited States

Signal score90

Kura OncologyEst. 2014

Troy WilsonUnited States

Signal score90

BridgeBioEst. 2014

Frank McCormickUnited States

Signal score90

Replicate BioscienceEst. 2021

AGAndy GeallUnited States

Signal score70

Book a demo to explore the full alumni network →

Global footprint

Where Avidity Biosciences has talent and traffic

AI talent share

133.3% of workforce is AI talent
(4 of 3 staff)

Core AI133.33%

Other AI3100%

Non-AI workforce00%

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

17K monthly visits
across markets

🇺🇸 United States57.6%

🏳️ Korea16.5%

🏳️ Republic of12.9%

🇮🇳 India5.9%

🇬🇧 United Kingdom4.1%

Top 5 markets shown

Patent intelligence

$50M patent portfolio · 42 active families

Estimated portfolio value

$50M

5.5× smaller than top peer argenx ($275M)

42 active patent families

Where Avidity Biosciences innovates Molecular biologyNucleic acidPharmaceutical drugOligonucleotideBiochemistry

Where Avidity Biosciences concentrates vs peers

Each axis is a top-10 topic across Avidity Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Avidity Biosciences

An AI-synthesized read of the highest-engagement posts about Avidity Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Avidity Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles